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Abstract:  The  6-hydroxytrypargine  (6-HT)  is  an  alkaloidal  toxin  of  the  group  of 
tetrahydro--carbolines  (THC)  isolated  from  the  venom  of  the  colonial  spider  
Parawixia bistriata. These alkaloids are reversible inhibitors of the monoamine-oxidase 
enzyme (MAO), with hallucinogenic, tremorigenic and anxiolytic properties. The toxin  
6-HT was the first THC chemically reported in the venom of spiders; however, it was not 
functionally  well  characterized  up  to  now.  The  action  of  6-HT  was  investigated  by 
intracerebroventricular (i.c.v.) and intravenous (i.v.) applications of the toxin in adult male 
Wistar rats, followed by the monitoring of the expression of fos-protein, combined with the 
use of double labeling immunehistochemistry protocols for the detection of some nervous 
receptors  and  enzymes  related  to  the  metabolism  of  neurotransmitters  in  the  central 
nervous system (CNS). We also investigated the epileptiform activity in presence of this 
toxin. The assays were carried out in normal hippocampal neurons and also in a model of 
chronic epilepsy obtained by the use of neurons incubated in free-magnesium artificial 
cerebro-spinal fluid (ACSF). Trypargine, a well known THC toxin, was used as standard 
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compound for comparative purposes. Fos-immunoreactive cells (fos-ir) were observed in 
hypothalamic and thalamic areas, while the double-labeling identified nervous receptors of 
the sub-types rGlu2/3 and NMR1, and orexinergic neurons. The 6-HT was administrated 
by perfusion and ejection in “brain slices” of hippocampus, inducing epileptic activity after 
its administration; the toxin was not able to block the epileptogenic crisis observed in the 
chronic model of the epilepsy, suggesting that 6-HT did not block the overactive GluRs 
responsible for this epileptic activity. 
Keywords:  6-hydroxytrypargine;  fos  protein;  immunohistochemistry;  hypothalamus; 
hippocampus; epilepsy; NMDA; neurotoxicity 
 
1. Introduction 
Most spiders present neuroactive substances in their venom [1], which are characterized by different 
affinities by a series of different receptors and ionic neuronal channels [2]. During the predation, 
spiders  inject  neurotoxins able to  cause paralysis of their prey due  to  the blocking  actions  at the 
neuromuscular  junctions  and/or  at  the  central  nervous  system  (CNS);  generally  the  voltage-gated 
sodium (Nav) and voltage-gated calcium (Cav) channels constitute the most common targets of these 
toxins [2,3].  
Spider venoms are complex mixtures of proteins, peptides and non-peptides low molecular mass 
organic (NPLMM) molecules (Mr < 1 kDa), which act mainly on the nervous system and present a 
wide range of pharmacological effects on synaptic transmission. The purpose of the present manuscript 
is not to focus the peptidic toxins from spider venoms, which probably represents the most intensively 
studied class of spider toxins. The NPLMM compounds more frequently reported in these venoms are 
free acids (such as citric and lactic), glucose, free amino acids, biogenic amines (such as diaminopropane, 
putrescine, cadaverine, spermine, and spermidine), and neurotransmitters (such as aspartate, glutamate, 
serotonin, histamine, -butyric acid, dopamine, and epinephrine) [4]. Several of these compounds are 
neurotransmitters, whereas others block ion channels at the neuronal level. Generally, low molecular 
mass  neurotoxins  offer  great  potential  as  neurochemical  tools  to  investigate  the  nervous  system. 
Additionally, they may constitute new models for drug-screening in pharmaceutical and agrochemical 
industries  [5].  Despite  the  wide  number  of  NPLMM  compounds  already  characterized  in  these 
venoms, many others remain to be discovered.  
Some classes of NPLMM toxins have been reported in spider venoms, such as: (I) acylpolyamines: 
isolated from the venoms of orb-web-spiders; some of these compounds are neurotoxic and act as 
antagonists for different subtypes of ionotropic glutamate receptors, whereas others act on nicotinic 
acetylcholine receptors [5]; these toxins are non-competitive antagonists of glutamate receptors [6], 
and present neuroprotective actions as previously reported for JSTX-3, which blocks the epileptiform 
activity in hippocampal CA1 neurons in vitro [7,8]; (II) bis-(agmatine)-oxamide: isolated from the 
venom  of  the  “fisher-spider”,  Plectreurys  tristis  [9];  (III)  nucleoside-toxins:  mono  or  disulfated 
nucleoside compounds that are able to block kainate receptors and act on Cav1 calcium channels, such 
as the toxin HF-6 isolated from the venom of Hololena curta [10]; (IV) tetrahydro-β-carbolines: Toxins 2011, 3  
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alkaloid compounds isolated from the venom of the social spider Parawixia bistriata [11] and from the 
web droplets of the orb-web-spider Nephila clavipes [12]; these compounds are reversible inhibitors of 
MAO-I and -II of mammals, are lethal to insects and are neurotoxic and convulsivant to rats [13].  
The THβC are pharmacologically active, characterized by presenting hypotensive, hallucinogenic, 
tremorogenic and anxiolytic properties in humans [14]. These alkaloids have high affinity by different 
types of the receptors, such as benzodiazepinics [15,16], imidazolynics [17] and serotonergics [18].  
The  c-Fos  protein  is  a  member  of  a  family  of  immediate  early  gene  transcription  factors;  
amongst  the other members of this  family Jun  and Egr-1 proteins may be included, identified as  
proto-oncogenes. The basal expression of these genes is characteristically much reduced; however it 
may increase quickly in response to changes, such as metabolic stress or neuronal activation. The  
fos-protein is an inducible transcription factor, being used to indicate specific neuronal activation by 
different  types  of  growth  factors,  neuroactive  drugs,  and  seems  to  be  correlated  with  changes  in 
behavioral or physiological states. The immunostaining of fos-protein can provide a mapping of the 
post-synaptic stimulation in the central nervous system, with high resolution at a cellular level. It is 
important to highlight that the expression of fos-protein can be detected in the nuclei of neurons, but 
not in glial cells [19–21]. The number of fos-ir cells is directly related to the intensity of a specific 
stimulus,  i.e.,  the  greater  the  stimulation,  the  greater  the  number  of  cells  expressing  fos-protein.  
In order to characterize the biochemical nature of some important receptors from the neurons of the 
brain  regions  responding  to  certain  stimuli,  a  protocol  of  double  labeling  imunohistochemistry  is 
generally used to identify and to co-localize specific sub-type of receptors, with the sites of fos-protein 
expression. While the immunohistochemistry protocol for fos-protein labels the nuclei of stimulated 
neurons, the staining for the specific receptors occurs in the soma, permitting the visualization of the 
double labeling of stimulate cells.  
Another strategy used to characterize the action of neurotoxins in rat brain is the investigation of the 
effects of these toxins in a model of chronic epilepsy in vitro by using patch-clamp electrophysiology 
in brain slices [7,22]. 
Figure 1. Chemical structure of the toxin 6-hydroxytrypargine (PWTX-II). 
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The compound 6-HT, also known as the spider toxin PWTX-I (Figure 1), is well characterized 
chemically [13]; however it is poorly characterized functionally. The main purpose of the present work 
was to investigate some actions of 6-HT in rat brain, by monitoring the expression of fos-protein, as a 
marker of the neuronal activation after i.c.v. and i.v. administration of the toxin, associated to the 
double labeling immunohistochemical protocol to identify the biochemical/pharmacological nature of 
the neurons, which are the site of action of 6-HT. The alkaloidal spider toxin was also submitted to 
investigation in a model of chronic epilepsy in vitro with hippocampal brain slices. Apparently, the 
results indicate that 6-HT acts in different brain regions, at the level of different sub-types of glutamate 
receptors and orexinergic neurons. Experiments of electrophysiology suggested that 6-HT may induce 
epileptogenic crisis, apparently by opening the calcium channels of glutamatergic neurons. 
2. Materials and Methods 
2.1. Animals  
Normal 90-days old male Wistar rats, weighing 250–300 g were housed two per cage with food and 
water ad libitum in a temperature controlled (21 ±  2 C) room on a 12 h light-dark cycle from one 
week prior to experimentation to allow them to acclimate to their new environment. All experiments 
were carried out in accordance with the guidelines of the Institutional Committee for Research and 
Animal Care of the University of Sã o Paulo and the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals [23]. 
2.2. 6-Hydroxytrypargine (6-HT) and Trypargine 
The toxins 6-hydroxytrypargine and trypargine were synthesized using the protocol of synthesis of 
tetrahydrocarbolines, with adaptations for each compound as previously reported [13,24].  
2.3. Monitoring the Expression of Fos-Protein  
The  method  employed  was  performed  as  previously  reported  [25–27].  The  guide  cannula  was 
implanted in the lateral ventricle (AP = −0.4; ML = −1.4; DV = −3.4) under anesthetic action of a 
cocktail (0.2 mL/100 g) containing ketamine (1 mg), xylazine (5 mg), and acepromazine (0.2 mg) 
seven days before the application of 6-HT. The animals were manipulated twice a day for 10 min to 
avoid stress on the day of the experiment. The injection cannula was introduced approximately two 
hours before the experiment to acclimate the animals and to minimize stress. The toxin 6-HT was 
solubilized in 10 µL of saline (0.9% w/v), and the compound was i.c.v. injected at a concentration of  
10 ng/L. The control group (n = 6) received only vehicle injection (saline: 0.9% w/v) to compare the 
effects of 6-HT administered in vehicle. Two hours was necessary for effective fos-protein induction. 
The animals were then anesthetized with a lethal dose of the same anesthetic cocktail used in the 
surgery (3 mL, intraperitoneal application) and perfused via the ascending aorta with cold 0.9% (m/v) 
saline (100 mL) followed by 4% (m/v) formaldehyde at pH 9.5 and 4 C (800–1000 mL).  
The brains were removed from the skull, post-fixed during four hours in the same fixative with the 
addition of 20% (m/v) sucrose and then transferred to 0.02 M potassium phosphate-buffered saline 
(KPBS) at pH 7.4 with 20% (m/v) sucrose. The brains were sliced in four series of coronal sections  Toxins 2011, 3  
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(at bregma 2.70 mm, −0.30 mm, −1.80 mm, and −3.14 mm) at a thickness of 30 µm with the use of a 
freezing microtome and stored at −20 C in buffered antifreeze solution [27].  
One series  of each brain  slice was  stained by immunohistochemistry as follows:  sections  were 
treated in  0.3% (v/v) peroxide in  KPBS + 0.3% (v/v) Triton X-100 for 30 min and incubated in 
primary antiserum anti-fos-protein (PC38T IgG anti-c-Fos (Ab5) (4–17) rabbit polyclonal antibody 
(Calbiochem, La Jolla, CA, USA) at 1:5,000 and 3% (v/v) normal goat serum in KPBS + 0.3% (v/v) 
Triton X-100 for 18 h at room temperature. Sections were rinsed in KPBS and incubated for 1 h in 
biotinylated secondary antiserum made from goat anti-rabbit antibody (Jackson Labs 1:1000) for one 
additional  hour  in  avidin-biotin  complex  (Vector,  1:500).  Next,  the  sections  were  incubated  in 
diaminobenzidine tetrahydrochloride (DAB; Sigma Chem Co.) and 0.01% (v/v) hydrogen peroxide 
dissolved in KPBS. The reaction was terminated after 2–3 min with repeated rinses in KPBS.
 Sections 
were mounted on slides and intensified with 0.005% (m/v) osmium tetroxide solution. To aid in the 
identification of brain regions presenting little or no fos-protein immunoreactive neurons (mainly in the 
sections of control brain slices), Nissl method of counterstaining with thionin was used [28]. 
Photomicrographs  were  acquired  through  a  Spot  RT  digital  camera  (Diagnostics  Instruments) 
adapted to a Leica DMR microscope and an Apple Macintosh Power PC computer using the software 
Adobe Photoshop 5.0. Contrast, sharpness, color balance and brightness were adjusted and images 
were combined in plates using Corel Draw 11 software.  
2.4. Double Labeling Immunohistochemistry  
Dual-label  immunohistochemistry  was  performed  as  reported  in  previous  studies  [25–27].  The 
sections presenting fos-ir neurons were rinsed in KPBS and then individually incubated with different 
antibodies:  anti-NMR1  (1:1000;  Santa  Cruz  Biotechnology),  anti-tyrosine-hydroxylase  (anti-TH) 
(1:1000;  Santa  Cruz  Biotechnology)  and  anti-orexin  (1:5000;  Oncogene),  overnight  at  room 
temperature.  The  sections  were  then  incubated  in  1,2-diaminobenzene  (DAB)  as  chromogen  and 
0.01%  (v/v)  hydrogen  peroxide  in  KPBS.  The  reaction  was  terminated  following  2–3  min  with 
repeated rinses in KPBS. Sections were mounted in slides and intensified with 0.005% (m/v) osmium 
tetroxide solution. 
2.5. Venous Catheterization 
For the intravenous (i.v.) administration of 6-HT, the rats were anesthetized with chloral hydrate 
(7%,  350  mg/kg,  i.p.)  and  submitted  for  venous  catheterisation.  A  Silastic  catheter  containing 
heparinized saline (10 U/mL of pyrogen-free saline, Sigma, St. Louis, MO, USA) was inserted into the 
femoral vein and sutured in place. The free end of the catheter was passed under the skin of the back, 
exteriorized  between  the  scapulae,  and  plugged  with  a  sterile  wire  stylet.  The  animals  were 
manipulated twice a day during 10 min to avoid stress on the day of the experiment. A week later,  
6-HT (100 ng kg
−1) was intravenously applied. Toxins 2011, 3  
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2.6. Statistical Analysis 
For the quantitative analysis of fos-ir and/or NMR1-ir cells, three representative slices of each brain 
region were chosen for each rat. All of the areas expressing c-Fos/NMR1 protein were included in the 
analysis. Three different animals were used in this protocol. The number of cells was counted in a 
defined area as follows: 0.25 mm
2 for the piriform cortex, 0.5 mm
2 for the lateral septal nucleus dorsal, 
paraventricular nucleus of the hypothalamus, dorsomedial hypothalamic nucleus, reuniens nucleus, 
central  medial  nucleus,  dorsal  intermediate  nucleus,  and  1  mm
2  for  the  paraventricular  thalamic 
nucleus and the pre-limbic cortex. The statistical analyses were performed using SigmaStat software 
and Student’s t-test was used for comparisons between groups (p < 0.05). 
2.7. Electrophysiological Assay 
For the electrophysiology assays normal male Wistar rats as described above were used. In order to 
ease pain and discomfort the animals were anesthetized via intraperitoneal (i.p.) injection of thiopental 
(40 mg/kg) before decapitation. Their brains were rapidly removed and the medial part containing the 
hippocampus was sectioned coronally in 400 µm thick and allowed to recover for at least 1 h before 
being transferred to a submersion-type recording chamber and placed on a nylon net submerged in a 
dissection artificial cerebrospinal fluid (ACSF) containing: 130 mM NaCl; 24 mM NaHCO3; 10 mM 
D-glucose; 1.3 mM NaH2PO4; 3.5 mM KCl; 2 mM Mg
2+; 2 mM CaCl2; previously gassed with a gas 
mixture containing 95% O2 and 5% CO2 and pH 7.4. About two slices per rat was used in these 
electrophysiological recordings. 
2.8. Electrophysiological Recordings, Data Acquisition and Analysis 
Ictal-like activity and interictal discharges were induced by omitting Mg
2+ ions from the oxygenated 
ACSF (0-Mg
2+ ACSF) and pH 7.4. During this ictal-like activity the 0.1 µM 6-HT diluted in ACSF 
was applied by ejection through a pneumatic pump (PV830 Pneumatic Pico Pump WPI), placed next 
to the intracellular electrode in the CA1 hippocampal region.  
The recording protocols as well as stimulation for current clamp were carried out using an in vitro 
electrophysiological system [29], inside a Faraday cage. Recordings were performed in the target cell 
on the CA1 hippocampal layer, by using borosilicate micropipette (electrode impedance 80–100 M) 
filled  with  3  M  potassium  acetate  for  intracellular  recordings  (IC)  or  ACSF  (5–10  M)  for 
extracellular recordings (EC) as previously reported [7,8]. Cyber Amp 380 (Axon Instruments Inc., 
USA) programmable signal conditioner was used, and current-clamp recordings were performed using 
an  Axoclamp-2B  amplifier  (AxoClamp  2B,  Axon  Instruments  Inc.,  Union  City,  CA,  USA).  The 
parameters used to verify the viability of a neuron were membrane potential, input resistance and 
action potential amplitude. Only neurons  with membrane potential of at least  −50 mV and action 
potentials  with  amplitude  higher  than  50  mV  were  studied.  Electrophysiological  variables  were 
measured as previously described [30]. Briefly, 200 ms negative and positive current pulses were 
injected into the cell (−0.7 to +0.7 nA) in 0.1 nA increments. The input resistance was calculated by 
plotting the steady-state voltages versus negative current amplitudes and measuring the slope of a 
linear regression of the plot.  Toxins 2011, 3  
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Furthermore, only slices in which ictal-like activity was present after 30 min perfusion with 0-Mg
2+ 
ACSF  were  studied.  The  data  were  monitored  and  recorded  on  a  personal  computer  via  the  
AxoScope software (Axon Instruments) and analyzed off-line with the Origin 5.0 software (Microcal 
Software Inc.).  
The electrophysiological protocol for the model of 0-Mg
2+ ACSF consisted of: (A) perfusion of 
cells with normal ACSF for 30 min; (B) perfusion with 0-Mg
2+ ACSF (30 min); (C) application of  
6-HT (ejection); and (D) Washout of 6-HT with normal ACSF during 10 min.  
3. Results  
3.1. Imunohistochemistry Assays 
The  i.c.v.  application  of  the  6-HT  in  Wistar  rats  revealed  the  neuroactive  character  of  this 
compound.  The  fos-ir  neurons  were  observed  mainly  in  hypothalamic  regions  and  some  thalamic 
nuclei. The labeling of fos-ir neurons were observed in the lateral hypothalamic area (LH), sensorial 
cerebral cortex (S), lateral septal nucleus (LSN), paraventricular nucleus of the hypothalamus (PVH), 
lateral pre-optic area (LPO), zona incerta (ZI), dorsomedial nucleus of the hypothalamus (DMH), in 
the  periventricular  nucleus  (Pe),  perifornical  region  (Pf),  hippocampus  and  some  thalamic  nuclei: 
paraventricular nucleus of the thalamus (PVA), reuniens (Re), central medial (CM), rhomboid (Rb), 
centro-lateral (CL) and paracentral (PC) (Figure 2). 
Cells were counted in the twelve regions which presented the most intense labeling and compared 
to the control (non-treated) animals. The counting results are shown in Figure 3, which clearly permits 
identification  of  differences  in  fos-protein  expression  between  groups  of  6-HT-treated  versus  
non-treated  animals,  indicating  the  action  of  the  6-HT  on  the  CNS  of  the  Wistar  rats.  Statistical 
analysis revealed that all regions presented a significant number of fos-ir neurons. 
The  i.v.  application  of  the  6-HT  in  Wistar  rats  showed  the  compound  was  able  to  cross  the 
hematoencephalic barrier, and the labeling of fos-ir neurons revealed that 6-HT reached and acted in 
the same the regions of the brain previously observed in i.c.v. applications, with the exception of the 
anterior hypothalamic area (AHA), piriform cortex (Pir) and central and medial nuclei of the amygdala 
(Ce and Me)(Figure 4). 
The toxin 6-HT is a THβC as is trypargine, a neurotoxin well characterized in the literature by its 
action in the CNS. For comparative purposes, trypargine was used as a standard compound, and i.c.v. 
applied in the brain of male Wistar rats, as described above for the 6-HT. The results of the labeling of 
fos-ir neurons are shown Figure 5, which revealed a similar pattern of labeling induced by 6-HT. The 
fos-ir cells were observed in lateral septal nucleus (LSN), paraventricular nucleus of hypothalamus 
(PVH),  lateral  hypothalamic  area  (LH)  and  some  thalamic  nuclei:  paraventricular  nucleus  of  the 
thalamus (PVA), central medial (CM), centrolateral (CL) and paracentral (PC). 
 Toxins 2011, 3  
 
 
149 
Figure 2. Photomicrography showing the areas of fos-expression after administration i.c.v. 
of the 6-HT and controls (saline). Sensorial cerebral cortex 6-HT (A)  and  control (B); 
lateral hypothalamic area and periventricular nucleus: 6-HT (C) and control (D); lateral 
septal nucleus: 6-HT (E) and control (F); paraventricular nucleus of the hypothalamus:  
6-HT  (G)  and  control  (H);  dorsomedial  nucleus  of  the  hypothalamus:  6-HT  (I)  and  
control  (J);  nuclei  thalamus,  paraventricular  nucleus  of  the  thalamus,  reuniens,  central 
medial, rhomboid, centrolateral, paracentral and zona incerta: 6-HT (K) and control (L); 
hippocampus:  6-HT  (M)  and  control  (N).  Abbreviations:  3v:  third  ventricle;  CA1: 
hippocampal region of CA1; CA2: hippocampal region of CA2; CA3: hippocampal region 
of CA3; cc: central comissure; CL: centrolateral; CM: central medial; DMH: dorsomedial 
nucleus of the hypothalamus; f: fornix; LH: lateral hypothalamic area; LSN: lateral septal 
nucleus;  LV:  lateral  ventricle;  Pe:  periventricular  nucleus;  PC:  paracentral;  PVA: 
paraventricular  nucleus  of  the  thalamus;  PVH:  paraventricular  nucleus  of  the 
hypothalamus, Rb: rhomboid; Re: reuniens; S: sensorial cerebral cortex; ZI: zona incerta. 
Scale bars: 200  m  in  C, D;  150  m  in  E,  F;  100  m  in  A,  B, G–N.  I, II and  III: 
Schematic representation of the fos-ir area. 
 Toxins 2011, 3  
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Figure 3. Number of fos-ir neurons counted in each brain area after administration of 6-HT 
(filled bars) or saline (open bars). Differences between both groups of animals for each 
encephalon  region  were  evaluated  with  Students’  t-tests.  Results  are  expressed  as  
means ±  S.D. (n = 6). Values of p < 0.05 were considered significant. CL: centrolateral; 
CM: central medial; DMH: dorsomedial nucleus of the hypothalamus; HIP: hippocampus; 
LH:  lateral  hypothalamic  area;  LSN:  lateral  septal  nucleus;  PC:  paracentral;  
PVH:  paraventricular  nucleus  of  the  hypothalamus,  Re:  reuniens;  S:  sensorial  cerebral 
cortex; ZI: zona incerta.  
 
The identification of the biochemical/pharmacological nature of the fos-ir neurons to 6-HT occurred 
through  the  use  of  the  double-labeling  technique  with  anti-bodies  anti-rGlu2/3,  anti-NMR1,  
anti-tyrosine-hydroxylase and anti-orexin. A series of other receptors characteristics of neurons from 
CNS  could  have  been  used;  however,  the  option  was  made  for  those  more  commonly  and 
experimentally well characterized by this technique. The double-labeling was not observed in  any  
fos-ir neuron for tyrosine-hydroxylase [Figure 6(A,B)], however, the labeling for rGlu2/3, NMR1 and 
orexin were observed in different regions of rat brain stimulated by 6-HT [Figure 6(C–L)], such as: 
CA1  hippocampal  region  (CA1),  lateral  hypothalamic  area  (LH),  lateral  septal  nucleus  (LSN), 
paraventricular nucleus of the hypothalamus (PVH), and sensorial cortex (S1). The fornix was also 
labeled for orexin and NMDAr1, however, this region was not fos-ir in 6-HT-treated animals. 
3.2. Electrophysiological Assay 
In  order  to  study  the  effect  of  6-HT  on  the  epileptiform  activity  induced  by  this  toxin  the 
intracellular potentials were recorded on hippocampal neurons from untreated rats (n = 3) kept in 
normal ACSF during 30 min [Figure 7(II), stage A; Figure 7(V) stages A and D] and in untreated rats 
kept in 0-Mg
2+ ACSF [Figure 7(V), stage B]. A total number of six neurons were studied (two neurons 
per rat) Treatment with 6-HT (0.1 µM) by ejection (n = 3; 30 min) [Figure 7(II), stage B] and ejection 
[Figure 7(V), stage C], induced spontaneous  interictal and ictal-like discharges  in  CA1 pyramidal 
neurons [Figure 6(II), stage C and Figure 7(V), stages A and B]. I versus V curves carried out before 
and following the aforementioned experimental protocol indicate that treatment with 6-HT does not 
significantly alter the membrane potential [Figure 7(III,VI) and Table 1]. The epileptiform activity 
induced by the perfusion with 0-Mg
2+ ACSF showed in Figure 6(V), stage B is due in part, to the relief 
of  the  NMDA  receptor  channel  from  the  gating  effect  of  Mg
2+  [8].  When  6-HT  was  applied  in  
this model it was able to amplify epileptiform activity observed in vitro induced by 0-Mg
2+ ACSF  Toxins 2011, 3  
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[Figure 6(V), stage C].  Apparently, the  action is  reversible since the washing  with  normal ACSF 
regenerated  the  pattern  of  spikes  observed  in  presence  of  Mg
2+  ions  [Figure  7(V),  stage  D]. 
Electrophysiological neuronal properties before and after 6-HT ejection are presented in Table 1.  
Figure 4. Photomicrography showing the areas of fos-expression after administration i.v. 
of 6-HT and controls (saline). Piriform cortex: 6-HT (A) and control (B); lateral septal 
nucleus: 6-HT (C) and control (D); anterior and lateral hypothalamic area: 6-HT (E) and 
control  (F);  paraventricular  nucleus  of  the  hypothalamus:  6-HT  (G)  and  control  (H); 
dorsomedial nucleus of the hypothalamus: control (E) and venom (F); lateral hypothalamic 
area and periventricular nucleus: control (G) and venom (H); central and medial nuclei of 
the amygdala: 6-HT (I) and control (J); paraventricular nucleus of the thalamus, reuniens, 
central  medial,  rhomboid,  centrolateral  and  paracentral:  6-HT  (K)  and  control  (L); 
hippocampus: 6-HT (M) and control (N). Abbreviations: 3v: third ventricle; CA1: hippocampal 
region  of CA1; CA2: hippocampal region  of CA2; CA3: hippocampal region  of CA3;  
cc: central comissure; Ce: central nucleus of the amygdala; CL: centrolateral; CM: central 
medial;  DMH:  dorsomedial  nucleus  of  the  hypothalamus;  f:  fornix;  LH:  lateral 
hypothalamic area; LSN: lateral septal nucleus; LV: lateral ventricle; Me: medial nucleus 
of the amygdala; Pe: periventricular nucleus; PC: paracentral; PVA: paraventricular nucleus of 
the thalamus; PVH: paraventricular nucleus of the hypothalamus, Rb: rhomboid; Re: reuniens; 
VM: ventro medial nucleus; ZI: zona incerta. Scale bars: 200 m in E, F; 100 m in C, D, 
G–N; 50 m in A, B, I. II and III: schematic representation of the areas fos-ir. 
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Figure 5. Photomicrography showing the areas of fos-expression after administration of 
the trypargine and controls (saline). Lateral septal nucleus: trypargine (A) and control (B); 
paraventricular  nucleus  of  the  hypothalamus:  trypargine  (C)  and  control  (D); 
paraventricular nucleus of the thalamus, reuniens, central medial, rhomboid, centrolateral 
and  paracentral:  trypargine  (E)  and  control  (F);  lateral  hypothalamic  area  and 
periventricular nucleus:  control (G) and venom  (H). Abbreviations: 3v: third ventricle; 
CL: centrolateral;  CM:  central  medial;  LH:  lateral  hypothalamic  area;  LHb:  lateral 
habenula;  LSN:  lateral  septal  nucleus;  LV:  lateral  ventricle;  PC:  paracentral; 
PVA: paraventricular  nucleus  of  the  thalamus;  PVH:  paraventricular  nucleus  of  the 
hypothalamus.  Scale  bars:  200  m  in  A,  B;  E,  F;  100  m  in  C,  D,  G,  H.  I  and  II: 
schematic representation of the areas fos-ir. 
 
Table  1.  Effects  of  6-hydroxytryptargine  on  electrophysiological  properties  of  CA1 
hippocampal neurons. 
  Control  After 6-HT Perfusion 
Vm (mV)  −71.63 ± 5.09  −76,07 ± 10.31 
Rin (MΩ)  42.7 ±  7.03  54,41 ±  8,17 
Tm (ms)  11.43 ±  2.97  10.90 ±  3.60 
Spike Amplitude (mV)  79.33 ±  10.97  84.33 ±  12.52 
Vm,  resting  membrane  potential;  Rin  input  resistance;  Tm,  Time  constant  of  the  membrane 
measured at Vm. All entries are expressed as means ±  S.D. Toxins 2011, 3  
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Figure 6. Photomicrography showing the areas of co-localization of the double labeling. 
fos and tyrosine hydroxylase (TH): paraventricular nucleus of the hypothalamus (A, B, and 
C); fos and orexin: lateral hypothalamic area (D, E and F); fos and rGlu2/3: lateral septal 
nucleus (G), paraventricular nucleus of the hypothalamus (H) and sensorial cortex (I); fos 
and NMDA-R1:  hippocampal region  of CA1 (J), sensorial  cortex (K) and perifornical 
region (L). Abbreviations: Abbreviations: 3v: third ventricle; CA1: hippocampal region of 
CA1; f: fornix; LH: lateral hypothalamic area;  LSN: lateral septal nucleus;  LV: lateral 
ventricle; PVH: paraventricular nucleus of the hypothalamus, S1: sensorial cortex. Scale 
bars: 150 m in D; 100 m in A, E; 50 m in B, C, L; 25 m in F, H, I, J, K. 
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Figure  7.  Electrophysiology  assay  of  the  6-HT  in  hippocampal  neurons  of  CA1.  
(I) Schematic slice of the hippocampus. (II) electrophysiologic recording of the perfusion 
of  the  6-HT  in  basal  state.  (III)  respective  I-V  curve.  (IV)  Slice  of  the  hippocampus.  
(V) electrophysiologic recording of the perfusion in model of the 0-Mg
2+ with the injection 
of the 6-HT. (VI) respective I-V curve. 
 
4. Discussion 
THβC  compounds are  endogenous  in  some animals,  and generally are found at  trace levels  in 
mammalian  brain  [31].  These  alkaloids  probably  arise  endogenously  in  mammalian  from  the 
condensation of central nervous system indolamines (or their precursor amino acid, L-tryptophan) with 
an aldehyde or α-keto acid via Pictet–Spengler reaction [32]. These alkaloids act on various aspects of 
neurotransmission  modulation,  and  are  neurotoxic  since  they  constitute  a  family  of  high  affinity 
ligands  of the benzodiazepine receptors,  which is  a sub-type of GABA receptor  [33]. The THC 
compounds are structurally  related to  the serotonin molecules [34], and because of this  structural 
similarity these alkaloids are capable of binding to multiple receptors, such as benzodiazepinic [15,16], 
imidazolynic [17] and serotonergic types [35]. Trypargine, a β-carboline isolated from the skin of the 
African frog Kassina senegalensis [36], has been studied since the 1980s; it is known to cause an 
action-related inhibition of Na
+ and Ca
2+ ions current when applied in internal surface of squid axonal 
membranes, and also a modulatory action in 5-hydroxytryptamine-like receptors [37,38]. Alkaloidal 
toxins such as 1-3-guanidinopropyl-6-hydroxy-1,2,3,4-tetrahydro-β-carboline and 1-4-guanidinobutoxy-
6-hydroxy-1,2,3,4-tetrahydro-β-carboline, known as PwTx-I and -II respectively, are THβC compounds 
isolated from  the venom  of the colonial  spider  P. bistriata.  Meanwhile, the indolylalkaloid  toxin, 
known as NWTx-I was isolated from the oily droplets of the web of the spider N. clavipes. These 
compounds are part of the chemical weaponry to kill/paralyze the Arthropod preys of the orb-weaving 
spiders [12], and are also neurotoxic, convulsive and lethal to rats [11,12,39]; however, little is known 
about the mechanisms of action of these toxins.  Toxins 2011, 3  
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Monoamine oxidases (MAOs) are flavin adenine dinucleotide-containing enzymes involved in the 
oxidative deamination of endogenous amines such as serotonin, noradrenaline and dopamine; these 
enzymes are ubiquitous and are localized in  the outer mitochondrial membranes of mammals and 
arthropods [13]. Two different forms of this enzyme have been identified in mammals, MAO-A and 
MAO-B, which differ in their amino acid sequences, three-dimensional structures, substrate affinities 
and sensitivities to different inhibitors [40]. Abnormal levels of MAO-B are frequently associated with 
neurological  disorders,  while  abnormalities  in  MAO-A  activity  are  frequently  associated  with 
psychiatric conditions [41]. High levels of anxiety have been reported in patients bitten by the black 
widow spider (Latrodectus mactans) [42] or stung by centipedes [43]. Toxins from the venoms of 
other organisms, such as scorpions (Mesobuthus gibbosus and Mesobuthus tamulus concanesis), have 
been reported to inhibit the MAO enzymes from mammals [44]. Apparently, the inhibition of MAO 
enzymes may be responsible for the anxiety effects generally associated to these envenomations [44]. 
Inhibition of the deamination of endogenous amines of the victims of spider bites may be an important 
aspect of the envenomation mechanism of venomous arthropods; recently it was demonstrated that the 
6-HT (PwTx-I) is a non-competitive inhibitor of (MAO)-A and -B [13]. 
Some THβC were described as psycho-stimulant compounds, being able to induce the expression of 
rapid transcription genes, such as the c-fos, in different areas of the CNS. Assays performed with  
N-methyl-β-carboline-3-carboxamide (FG-7142) revealed the expression of fos-protein in a series of 
brain  areas,  related  to  the  anxyolitic  behavior  [45].  Meanwhile,  experiments  with  the  β-carboline 
harman  demonstrated  a  thermorregulatory  action  in  mammals  [46].  The  β-carboline  alkaloids  are 
capable of promoting the extracellular release of 5-hydroxytryptamine in the inner pre-optical area, a 
region responsible for the central regulatory mechanism of temperature [47,48]. Ibogaine, also a THβC 
compound,  when  i.c.v.  administered  in  rat  brains,  induced  the  expression  of  fos-protein  in  the  
frontal-cortex, septal area (including the septal lateral nucleus), putamen-caudatum and hippocampus, 
suggesting  a  possible  change  in  the  neuroaminergic  transmission,  resulting  from  an  increase  of 
dopaminergic and/or serotonergic neurotransmission, which can be correlated to behavioral shifts [49]. 
The present study was undertaken in order to permit the identification of the brain regions and some 
of  the  receptors  which  are  the  target-sites  of  6-HT  (PwTx-I);  thus,  the  toxin  was  i.c.v.  and  i.v. 
administered  in  male  Wistar  rats  and  the  expression  of  fos-protein  in  different  brain  areas  was 
observed: lateral hypothalamic area (LH), lateral septal nucleus (LSN), paraventricular nucleus of the 
hypothalamus  (PVH),  lateral  pre-optic  area  (LPO),  zona  incerta  (ZI),  dorsomedial  nucleus  of  the 
hypothalamus (DMH), in the periventricular nucleus (Pe), perifornical region (Pf), hippocampus and 
some thalamic nuclei: paraventricular nucleus of the thalamus (PVA), reuniens (Re), central medial 
(CM), rhomboid (Rb), centrolateral (CL) and paracentral (PC) (Figures 2 to 5). All these areas are 
directly or indirectly related to the behavior of alert and attention while the animal is exposed to the 
action the toxin. The importance of the i.v. injection of 6-HT was the possibility to compare the results 
obtained in this form of toxin administration, with those results got through i.c.v. administration; the 
great similarity of fos-ir areas observed in both experiments suggests that, that 6-HT is capable of 
crossing the blood-brain barrier, as previously reported for other β-carbolines [50–52]. 
Due to the structural similarity between trypargine and 6-HT, and because of previous functional 
characterization of trypargine [37], it was proposed to trace a comparative pattern between the labeling 
of fos-protein expression for each one of these drugs. Both compounds caused a very similar labeling Toxins 2011, 3  
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pattern for fos-protein expression (mainly in the hypothalamic areas); thus, by comparison, it may be 
inferred that 6-HT may be acting preferentially at level of Na
+ and Ca
2+ ion
 channels. 
The double labeling experiments were carried-out with the objective of recognizing the neuronal 
types expressing fos-protein under effect of 6-HT administration. The first double labeling reaction 
was  performed with  tyrosine hydroxylase (TH), which is  an  enzyme involved in  the synthesis  of 
cathecolamines in the CNS. Although, it is known that the β-carbolines are involved in the regulation 
of the up-taking of some biogenic amines, by inhibiting the MAO activity [13], it was observed that 
none of the fos-ir neurons belonged to the cathecholaminergic system, since no fos/TH double labeling 
was observed [Figure 6(I), stages A, B and C].  
The  double  labeling  fos/orexin  revealed  that  about  30%  of  cells  from  the  lateral  and  dorsal 
hypothalamic areas corresponded to orexinergic neurons under effect of 6-HT [Figure 6(II), stages D, 
E and F]. Although the orexinergic neurons are found only in the dorsal and lateral hypothalamic area, 
in the perifornicial nucleus, and in the dorsomedial hypothalamic nucleus, they are generally widely 
distributed  through  the  projections  to  the  hypothalamic  area,  cerebral  cortex,  pons  and  thalamus, 
amongst other CNS areas [53-55]. According to these authors, the distribution of the fibers suggests 
that the orexinergic neurons can be involved in the regulation of the feeding behavior, blood pressure, 
hormonal release, temperature and alert behavior. 
The double labeling for the rGlu2/3 subtype AMPA-glutamate receptors (GluRs) represented a little 
more than 10% of the total cortical cells [Figure 6(III), stages G, H and I]. Meanwhile, the double 
labeling was expressive for the NMR1 sub-type of NMDA -GluRs) [Figure 6(IV), stages J, K and L]; 
53% of the cortical cells of the S1 region were double labeled). These results have shown that 6-HT 
does not seem to be highly selective for a specific sub-type of GluR. The AMPA- and NMDA-GluRs 
are  part  of  a  family  of  ionotropic  receptors;  thus,  the  double  labeling  fos/NMR1  and  fos/rGlu2/3 
neurons suggests that the 6-HT seems to present a similar action on Na
+ and Ca
2+ channels as reported 
for trypargine [34]. Considering that NMDA-GluRs have an important role in the convulsive state [45], 
the expression of fos-protein in NMR1 neurons is possibly related to the epileptogenic properties of this 
-carboline. 
For the study of 6-HT in electrophysiology assays, an induced epileptiform activity model based  
on  the  removal  of  the  Mg
2+  ions  from  the  ACSF  was  used  in  the  hippocampal  slice  perfusion,  
determining a hyper-excitability state due to the increase of the conductance of Na
+ and Ca
2+ ions on 
NMDA-GluRs [7,8]. In addition to this model, the effect of 6-HT administration on hippocampal slices 
infused with normal ACSF was also investigated with the objective of studying the action of this 
compound on the basal state of hippocampal neurons. 
The preparations of hippocampal neurons are rich in NMDA-GluRs, which consist of voltage-dependent 
channels partially blocked by Mg
2+ ions [7,8]; the Mg
2+ ions bind to the channels of NMDA-GluRs 
from neurons in resting potential, preventing the influx of other ions. Hippocampal slices exposed to 
Mg
2+-free medium showed hyperexcitability expressed as organized seizure-like activity due to influx 
of  Ca
2+  ions.  This  hyperexcitability  in  experimental  models  of  temporal  lobe  epilepsy  is  partially 
attributed to an increased function of a sub-population of glutamatergic synapses which uses NMDA 
receptors [56,57]. It is believed that not only the NMDA GluR-sub-types, but also the AMPA-GlusRs are 
involved in the epileptiform activity mechanisms [58–60], allowing changes in the permeability of Ca
2+ 
ions, with important consequences for other kinetic properties of these neurons [60]. Toxins 2011, 3  
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Experiments  performed  with  6-HT  demonstrated  an  epileptogenic  effect  of  this  toxin  on 
hippocampal  CA1  neurons,  when  perfused  with  normal  ACSF  solution.  In  addition  to  this,  the 
perfusion  assays  with  0-Mg
2+  ACSF  showed  that  6-HT  not  only  did  not  block  the  epileptogenic 
activity, but potentiated it even more, by increasing the frequency of the epileptic discharges.  
This synergic effect could be mediated by glutamatergic mechanisms. Along this line, the double 
labeling fos/NMR1 and fos/rGlu2/3 neurons suggest that the 6-HT does not seem to be highly selective 
for a specific sub-type of GluR and could explain the observed synergic effect since magnesium-free 
medium operates only in NMDA receptors. Thus, the 6-HT induced enhancement of neuronal firing 
without changing the membrane potential could be explained by this postsynaptic mechanism. It is 
most probable that a complete understanding of the actions of 6-HT on in vitro hippocampal neurons 
requires  far  more  knowledge  about  cell  membrane  behavior  than  is,  at  present,  available.  This  
suggests that 6-HT is an epileptogenic compound (pro-convulsant) that could be acting at the level of  
NMDA-GluRs, preventing the blockage of Na
+ and Ca
2+ channels.  
The -carbolines are also reported to cause hallucinogenic, tremorogenic and anxiolytic actions, 
probably due to the binding of these compounds to benzodiazepinic receptors [61–66]. 
The electrophysiological results obtained in the present investigation enabled the characterization of 
6-HT as a probable pro-convulsant compound with reversible action once the neurons had returned to 
their  normal  initial  condition  after  the  perfusion  with  normal  ACSF,  but  showed  more  negative 
membrane potentials than the initial potentials, indicating a neuronal hyperpolarization event due to 
the action of 6-HT [Figure 7(III,VI)].  
The association of imunohistochemical protocols, that enabled mapping the action of 6-HT in rat 
brain with electrophysiological assays, contributed to the elucidation of the action of the indolyl-alkaloid 
toxin on the mammalian CNS.  
5. Conclusions 
The toxin 6-hydroxytrypargine is an alkaloidal compound of the group of THC isolated from the 
venom  of  the  orb-weaving  spiders,  which  is  part  of  the  chemical  weaponry  to  kill/paralyze  the 
Arthropod prey of these spiders, but also seems to be neurotoxic to mammals. In order to identify the 
sites of action in rat brain and to get a better understanding about some of the mechanisms involved in 
the  neurotoxic  action  in  mammalian  brain,  the  action  of  6-HT  was  investigated  by  i.c.v.  and  i.v. 
applications  of  the  toxin  in  adult  male  Wistar  rats,  followed  by  monitoring  the  expression  of  
fos-protein,  combined  with  the  use  of  double  labeling  immune-histochemistry  protocols  for  the 
detection of some nervous receptors and enzymes related to the metabolism of neurotransmitters in 
CNS. Apparently, the toxin crosses the brain-blood barrier, acting on different brain regions, mainly in 
those  areas  directly  or  indirectly  related  to  behavioral  alertness  and  attention  while  the  animal  is 
exposed to the action of the toxin. Thus, it was observed that 6-HT stimulated the lateral hypothalamic 
area, lateral septal nucleus, paraventricular nucleus of the hypothalamus, lateral pre-optic area, zona 
incerta, dorsomedial nucleus of the hypothalamus, in the periventricular nucleus, perifornical region, 
hippocampus and some thalamic nuclei:  paraventricular nucleus of the thalamus,  reuniens, central 
medial, rhomboid, centrolateral and paracentral.  Toxins 2011, 3  
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The epileptiform activity in the presence of this toxin was also investigated. The assays were carried 
out in normal hippocampal neurons and also in a model of chronic epilepsy obtained by the use of 
neurons incubated in free-magnesium artificial cerebro-spinal fluid. Fos-immunoreactive cells were 
observed in hypothalamic and thalamic areas, while the double-labeling identified nervous receptors of 
the sub-types rGlu2/3 and NMR1, and orexinergic neurons. The 6-HT was administrated by perfusion 
and ejection in “brain slices” of hippocampus, inducing epileptic activity after its administration; the 
toxin  was  not  able  to  block  the  epileptogenic  crisis  observed  in  the  chronic  model  of  epilepsy, 
indicating  that  6-HT  did  not  block  the  overactive  GluRs  responsible  for  this  epileptic  activity. 
Apparently, these results are indicative that 6-HT is an epileptogenic compound (pro-convulsant) that 
could be acting at the level of NMDA -GluRs, preventing the blockage of Na
+ and Ca
2+ channels.  
Apparently orb-weaving spiders may be predated by different birds and mammals. The existence of 
a  polyfunctional  toxin,  that  can  act  both  on  a  web  to  kill/paralyze  the  prey  Arthropods,  or  as  a 
neurotoxin, causing convulsion and/or killing small mammals (depending on the dose), suggests an 
important chemical attribute that can be used to adapt the toxin both for hunting or defensive purposes. 
Acknowledgements 
This work was supported by a grant from the Sã o Paulo State Research Foundation (FAPESP, 
BIOprospecTA program 04/07942-2; 06/57122-7); L.M.M.C.T. was a Ph.D. student fellows from the 
CAPES.  M.S.P.,  J.C.B.,  C.F.E.  and  J.C.C.  are  researching  for  CNPq.  We  also  wish  to  thank  to 
Fernanda Noal Carlesso, Michele Franzen Pedroso, Raquel Mattos de Oliveira and Ricardo Vaz Breda 
for helping in the laboratory electrophysiological techniques and José  Amaro Martins and Fernanda de 
Borba Cunha for helping in the carefulness with the animals.  
References 
1.  Hagiwara, K.; Sakai, T.; Miwa, A.; Kawai, N.; Nakajima, T. Agelenin. A new neurotoxin from 
the venom of the spider. Agelena opulenta. Pept. Chem. 1991, 1, 351–356.  
2.  Glenn, F.; King, G.G. Modulation of insect Cav channels by peptidic spider toxins. Toxicon 2007, 
49, 513–530.  
3.  King, G.F.; Escoubas, P.; Nicholson, G.M. Peptide toxins that selectively target insect NaV and 
CaV channels. Channels 2008, 2, 100–116. 
4.  Escoubas, P.; Diochot, S.; Corzo, G. Structure and pharmacology of spider venom neurotoxins. 
Biochimie 2000, 82, 893–907.  
5.  Palma, M.S.; Nakajima, T. A Natural Combinatorial Chemistry Strategy in Acylpolyamine Toxins 
From Nephilinae Orb-Web Spiders. Toxin Rev. 2005, 24, 209–234.  
6.  McCormick, K.D.; Meinwald, J. Neurotoxic acypoliamines from spider venoms. J. Chem. Ecol. 
1993, 19, 2411–2451.  
7.  Salamoni, S.D.; Costa, J.C.; Palma, M.S.; Konno, K.; Nihei, K.; Tavares, A.A.; Abreu, D.S.; 
Venturin, G.T.V.; Cunha, F.B.; Oliveira, R.M.; Breda, R.V. Antiepileptic effect of acylpolyaminetoxin 
JSTX-3 on rat hippocampal CA1 neurons in vitro. Brain Res. 2005, 1048, 170–176.  Toxins 2011, 3  
 
 
159 
8.  Salamoni,  S.D.;  Da  Costa,  J.C.;  Palma,  M.S.;  Konno,  K.;  Ken-Ichi,  N.;  Tavares,  A.A.;  
Abreu, D.S.; Venturin, G.T.; Cunha, F.B.; Oliveira, R.M.; Breda, R.V. Antiepileptic effect of 
acypoliaminetoxin JSTX-3 on rat hippocampal neurons. Brain Res. 2005, 1048, 170–176. 
9.  Quistad, G.B.; Lam, W.W.; Casida, J.E. Identification of bis(agmatine)oxalamide in venom from 
the primitive hunting spider. Plectreurys tristis (Simon). Toxicon 1993, 31, 920–924.  
10.  Taggi,  A.E.;  Meinwald,  J.;  Schroeder,  F.C.  A  new  approach  to  natural  products  discovery 
exemplified by the identification of sulfated nucleosides in spider venom. J. Am. Chem. Soc. 
2004, 126, 10364–10369. 
11.  Cesar,  L.M.M.;  Tormena,  C.F.;  Marques,  M.R.;  Silva,  G.V.J.;  Mendes,  M.A.;  Palma,  M.S. 
Structure Determination of Hydroxytrypargine: A Tetrahydro-β-carboline Toxin From the Venom 
of the Spider Parawixia bistriata. Helvetica Chim. Acta 2005, 88, 796–801.  
12.  Marques,  M.R.;  Mendes,  M.A.;  Tormena,  C.F.;  Souza,  B.M.;  Cesar,  L.M.;  Rittner,  R.;  
Palma, M.S. Structure determination of a tetrahydro-beta-carboline of arthropod origin: A novel 
alkaloid-toxin subclass from the web of spider Nephila clavipes. Chem. Biodivers. 2005, 2, 525–534. 
13.  Saidemberg,  D.M.;  Ferreira,  M.A.;  Takahashi,  T.N.;  Gomes,  P.C.;  Cesar-Tognoli,  L.M.;  
Da Silva-Filho, L.C.; Tormena, C.F.; Da Silva, G.V.; Palma, M.S. Monoamine oxidase inhibitory 
activities of indolylalkaloid toxins from the venom of the colonial spider Parawixia bistriata: 
Functional characterization of PwTX-I. Toxicon 2009, 54, 717–724. 
14.  Martin, L.; Lé on, A.; Martin, M.A.; Del Castilho, B.; Mené dez, J.C. Detection and characterization 
of  cyclodextrin  complexes  with  -carboline  derivates  by  spectroscopic  techniques.  J.  Pharm. 
Biomed. Anal. 2003, 32, 991–1001.  
15.  Airaksinen, M.M.; Lecklin, A.; Saano, V.; Tuomisto, L.; Gynther, J. Tremorogenic effect and 
inhibition  of  tryptamine  and  serotonin  receptor  binding  by  -carbolines.  Pharmacol.  Toxicol. 
1987, 60, 5–8.  
16.  Mü ller,  W.E.;  Fehske,  K.J.;  Borbe,  H.O.;  Wollert,  U.;  Nanz,  C.;  Rommelspacher,  H.  On  the 
neuropharmacology of harmane and other -carbolines. Pharmacol. Biochem. Behav. 1981, 14, 
693–699.  
17.  Husbands, S.M.; Glennon, R.A.; Gorgerat, S.; Gough, R.; Tyacke, R.; Corsby, J.; Nutt, D.J.; 
Lewis,  J.W.;  Hudson,  A.L.  Beta-carboline  binding  to  imidazoline  receptors.  Drug  Alchohol 
Depend. 2001, 64, 203–208. 
18.  Glennon, R.A.; Dukat, M.; Grella, B.; Hong, S.; Constantino, L.; Teitler, M.; Smith, C.; Ergan, C.; 
Davis, K.; Mattson, M.V. Binding of -carbolines and related agents at serotonine (5-HT2 and  
5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug Alchohol Depend. 2000, 60, 121–132.  
19.  Morgan, J.I.; Curran, T. Stimulus-transcription coupling in the nervous system: Involvement of 
inducible proto-oncogenes fos and jun. Ann. Rev. Neurosci. 1991, 14, 421–451.  
20.  Lino de Oliveira, C.; Sales, A.J.; Del Bel, E.A.; Silveira, M.C.L.; Guimarã es, F.S. Effects of acute 
and chronic fluoxetine treatments  on restraint stress-induced  Fos  expression.  Brain  Res.  Bull. 
2001, 55, 747–754.  
21.  Kobelt, P.; Tebbe, J.J.; Tjandra, I.; Bae, H.G.; Klapp, B.F.; Wiedenmann, B.; Monnikes, H. Two 
immunocytochemical protocols for immunofluorescent detection of c-Fos positive neurons in the 
rat brain. Brain Res. Protocol. 2004, 13, 45–52. Toxins 2011, 3  
 
 
160 
22.  McIlmwain,  H.;  Buddle,  H.L.  Techniques  in  tissue  metabolism.1.  A  mechanical  chopper. 
Biochem. J. 1953, 53, 412–420.  
23.  National Academy of Sciences. Guide for the Care and Use of Laboratory Animals; Institute of 
Laboratory Animal Resources, Commission on Life Sciences, National Research Council, 1996. 
National  Academy  Press:  Washington,  DC,  USA.  Available  online:  http://www.nap.edu/ 
readingroom/books/labrats/ (accessed on 1 February 2011). 
24.  Shimizu, M.; Ishikawa, M.; Komoda, Y.; Nakajima, M. Total synthesis of (−)-Trypargine. Chem. 
Pharm. Bull. 1982, 30, 909–913. 
25.  Gerfen, C.R.; Sawchenko, P.E. An anterograde neuroanatomical tracing method that shows the 
detailed morphology of neurons, their axons and terminals: immunohistochemical localizations of 
an axonally transported plantlectin  Phaseolus  vulgaris leucoagglutinin.  Brain  Res. 1984,  290, 
219–238.  
26.  Shu, S.; Ju, G.; Fan, L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of 
the nervous system. Neurosci. Lett. 1988, 85, 169–171.  
27.  Sita, L.V.; Elias, C.F.; Bittencourt, J.C. Dopamine and melanin-concentrating hormone neurons 
are distinct populations in the rat rostromedial zona incerta. Brain Res. 2003, 970, 232–237.  
28.  Windle, H. A Nissl method using buffered solutions of thionin. Stain Tech. 1943, 18, 77–86. 
29.  Bashir, Z.I. Neuroscience; Lynch, M.A., O’Mara, S.M., Eds.; LABFAX Series; Academic Press: 
London, UK, 1997; pp. 13–31.  
30.  Jensen, M.S.; Azouz, R.; Yaari, Y. Spike after-depolarization and burst generation in adult rat 
hippocampal CA1 pyramidal cells. J. Physiol. 1996, 492, 199–210.  
31.  Barker, S.A.; Harrison, R.E.W.; Brown, J.G.B.; Christian, S.T. Identification and quantification of 
1,2,3,4-tetrahydro-b-carboline,  2-methyl-1,2,3,4-tetrahydro-b-carboline,  and  6-methoxy-1,2,3,4-
tetrahydro-b-carboline as in vivo constituents of rat brain and adrenal gland. Biochem. Pharmacol. 
1981, 30, 9–15.  
32.  Carmona, C.; Ghanem, R.; Baló n, M.; Muñ oz, M.A.; Guardado, P. Chemical and photochemical 
oxidation of tetrahydrobetacarboline. J. Photochem. Photobiol. A: Chem. 2000, 135, 171–177.  
33.  Robertson,  H.A.  Harmaline-induced  tremor:  The  benzodiazepine  receptor as  a  site  of  action.  
Eur. J. Pharmacol. 1980, 67, 129–132.  
34.  Solis-Maldonado,  C.;  Quintanilla-Licea,  R.;  Tamez-Guerra,  R.;  Rodriguez-Padilla,  C.;  
Gomez-Flores, R. Differential effects of synthetic indoloquinolizines on in vitro rat lymphocytes 
and macrophage functions. Int. Immunopharmacol. 2003, 3, 1261–1271.  
35.  Glennon, R.A.; Dukat, M.; Grella, B.; Hong, S.; Costantino, L.; Teitler, M.; Smith, C.; Egan, C.; 
Davis, K.; Mattson, M.V. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 
5-HT(1A)),  dopamine  (D(2))  and  benzodiazepine  receptors.  Drug  Alcohol  Depend.  2000,  60, 
121–132.  
36.  Akizawa,  T.;  Yamazaki,  K.;  Yasuhara,  T.;  Nakajima,  T.;  Roseghini,  M.;  Esparmer,  G.F.; 
Esparmer, M. Trypargine, a new tetrahydro--carboline of animal origin: Isolation and chemical 
characterization from the skin of the African rhacophorid frog. Kassina senegalensis Biomed. Res. 
1982, 3, 232–234.  
37.  Seyama, I.; Yakehiro, M.; Nakajima, T. Trypargine blocks tha sodium channels only from the 
inside of squid giant axon. JPN J. Physiol. 1985, 35, 367–373.  Toxins 2011, 3  
 
 
161 
38.  Nistico, G.; de Sarro, G.B.; Langer, S.Z. Behavioural and electrocortical power spectrum effects 
of  5-methoxytryptoline  and  other  analogs  after  intraventricular  administration  in  rats.  Eur.  J. 
Pharmacol. 1987, 142, 121–128.  
39.  Cesar,  L.M.M.;  Mendes,  M.A.;  Tormena,  C.F.;  Marques,  M.R.;  de  Souza,  B.M.;  
Saidemberg,  D.M.;  Bittencourt,  J.C.;  Palma,  M.S.  Isolation  and  chemical  characterization  of 
PwTx-II: A novel alkaloid toxin from the venom of the spider Parawixia bistriata (Araneidae, 
Araneae). Toxicon 2005, 46, 786–796.  
40.  Yamada,  M.;  Yasuhara,  H.  Clinical  pharmacology  of  MAO  inhibitors:  Safety  and  future. 
NeuroToxicology 2004, 25, 215–221.  
41.  Herraiz, T.; Chaparro, C. Analysis of monoamine oxidase enzymatic activity by reversed-phase 
high  performance  liquid  chromatography  and  inhibition  by  β-carboline  alkaloids  occurring  in 
foods and plants. J. Chromatogr. A 2006, 1120, 237–243.  
42.  Hoover, N.G.; Fortenberry, J.D. Use of antivenin to treat priapism after a black widow spider bite. 
Pediatrics 2004, 114, 128–129.  
43.  Yildiz, A.; Biç eroglu, S.; Yakut, N.; Bilir, C.; Akdemir, R.; Akilli, A. Acute myocardial infarction 
in a young man caused by centipede Sting. Emerg. Med. J. 2006, 23, 30–33. 
44.  Ucar,  G.;  Tasb,  C.;  Tü mer,  A.  Monoamine  oxidase  inhibitory  activities  of  the  scorpion 
Mesobuthus gibbosus (Buthidae) venom peptides. Toxicon 2005, 45, 43–52.  
45.  Singewald, N.; Salchner, P.; Sharp, T. Induction of c-Fos expression in specific areas of the fear 
circuitry in rat forebrain by anxiogenic drugs. Biol. Psych. 2003, 15, 275–283.  
46.  Adel, A.; Biggs, T.A.; Myers, R.D. Action of harman (1-methyl--carboline) on the brain: Body 
temperature and in vivo efflux of 5-HT from hippocampus of the rat. Neuropharmacology 1996, 
35, 1101–1107.  
47.  Myers, R.D. Serotonin and thermoregulation: Old and new views. Physiology (Paris) 1981, 77, 
505–513.  
48.  Harikai, N.; Tomogane, K.; Sugawara, T.; Tashiro, S. Differences in hypothalamic fos expression 
between two heat stress conditions in conscious mice. Brain Res. Bull. 2003, 61, 617–626.  
49.  Ali, S.F.; Thiriet, N.; Zwiller, J. Acute ibogaine injection induces expression of the immediate 
early gene, erg-1 and c-fos, in mouse brain. Mol. Brain Res. 1999, 74, 237–241.  
50.  Bac,  G.;  Seidel,  G.  Harmine  action  in  rats  with  lymphostatic  encephalopathy.  Pharmacology 
1977, 15, 127–133.  
51.  Leino, M.; Airaksinen, M.M.; Antikainen, R.; Gynther, J.; Kari, E.; Kari, I.; Peura, P. Distribution 
of  1,2,3,4-tetrahydro-beta-carboline  and  6-methoxy-1,2,3,4-tetrahydro-beta-carboline  in  mice. 
Acta Phamacol. Toxicol. 1984, 54, 361–371.  
52.  Krause, W.; Mengel, H. Pharmacokinetics of the anxiolytic beta-carboline derivate abecarnil in 
the mouse,  rat,  rabbit,  dog, cynomolgus monkey  and baboon. Studies  on species differences. 
Arzneimittelforschung 1990, 40, 522–529.  
53.  Peyron, C.; Tighe, D.K.; van del Pol, A.N.; Lecea, L.; Heller, H.C.; Sutcliffe, J.G.; Kilduff, T. 
Neurons containing Hypocretin (Orexin) project to multiple neuronal systems. J. Neurosci. 1998, 
18, 9996–10015.  
54.  Stone, T.W. Neurophamacology, 1st ed.; W.H. Freeman/Spektrum: New York, NY, USA, 1995; 
p. 140.  Toxins 2011, 3  
 
 
162 
55.  Prince, D.A.; Connors, B.W. Mechanisms of interictal epileptogenesis. Adv. Neurol. 1986, 44, 
275–299.  
56.  Kö hr,  G.;  Mody,  I.  Kindling  increases  N-methyl-D-aspartate  potency  at  single  N-methyl-D-
aspartate channels in dentate gyrus granule cells. Neuroscience 1994, 62, 975–981.  
57.  Bernard, C.; Wheal, H.V. Plasticity of AMPA and NMDA receptor-mediated epileptiform activity 
in a chronic model of temporal lobe epilepsy. Epilepsy Res. 1995, 21, 95–107.  
58.  Babb, T.L.; Matherm, G.W.; Leite, J.P.; Pretorius, J.K.; Yeoman, K.M.; Kuhlman, P.A. Glutamate 
AMPA receptors in the fascia dentata of human and kainate rat hippocampal epilepsy. Epilepsy 
Res. 1996, 26, 193–205.  
59.  Traub, R.D.; Jefferys, J.G.; Whittington, M.A. Enhanced NMDA conductance can account for 
epileptoform activity induced by low Mg
2+ in the rat hippocampal slice. J. Physiol. 1994, 478, 
379–393. 
60.  Nakanishi,  S.  Molecular  diversity  of  glutamate  receptors  and  implications  for  brain  function. 
Science 1992, 5082, 597–603.  
61.  Airaksinen, M.M.; Mikkonen, E. Affinity of -carbolines on rat brain benzodiazepine and opiate 
receptors. Med. Biol. 1980, 58, 341–344.  
62.  Saano, V.; Airaksinen, M.M. Binding of -carbolines and cafeine on benzodiazepine receptors: 
Correlation to convulsions and tremor. Acta Pharmacol. Toxicol. 1982, 51, 300–308.  
63.  Luttes, J.; Lorden, J.F.; Beales, M.; Lotmans, M.G.A. Tolerance to the tremorogenic effects of 
harmaline: Evidence for altered olivo-cerebellar function. Neuropharmacology 1988, 27, 849–855.  
64.  Rommelspacher,  H.;  Brü ning,  G.;  Susilo,  R.;  Nick,  M.;  Hill,  R.  Pharmacology  of  harmalan  
(1-methyl-3,4-dyhydro--carboline). Eur. J. Phamacol. 1985, 109, 363–371.  
65.  Rommelspacher, H.; May, T.; Salewski, B. Harman (1-methyl--carboline) is a natural inhibitor 
of monoamine-oxidase type A in rats. Eur. J. Pharmacol. 1994, 252, 51–59.  
66.  Pä hkla, R.; Harro, J.; Rä go, L. Behavioural effects of the pinoline in the rat forced swimming 
open field avd elevated plus-maze tests. Pharm. Res. 1996, 34, 73–78. 
© 2011  by the authors; licensee  MDPI,  Basel, Switzerland. This  article is  an open  access article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 